Bulk omega-3 fish oil supplier quotations are rarely comparable on price alone, because the same EPA+DHA figure can describe an ethyl ester concentrate or a triglyceride oil with different oxidation limits behind it. The four parameters that decide whether a lot fits a formulation are the chemical form, the oxidation limits, the concentration band, and the documentation.
What to fix before you compare price per kilogram
Price per kilogram of EPA+DHA is the last number a buyer should look at when choosing a bulk omega-3 fish oil supplier, because the four parameters that determine fitness for a formulation are settled before price becomes meaningful.
The supply data for omega-3 fish oil supports working in that order. Global omega-3 ingredient volume reached 136,000 metric tons in 2025, up 2.6% on 2024, while value fell 4.3% to $2.53 billion - a price correction rather than a demand collapse, following the 2023–2024 El Niño that restricted Peruvian anchovy oil supply and lifted refined oil prices before they normalized in late 2024. GOED's 2026 Ingredient Market Report projects volume growth of 3–4% a year through 2028.
Two structural facts from that report are worth carrying into a sourcing conversation. The United States and Europe remain the largest EPA and DHA markets, while China led growth in the most recent reporting year; pet nutrition demand is also rising quickly as a separate application. For scale, the same reporting series put 2021 volume at 115,031 metric tons and value at $1.53 billion. GOED data as reported in OFI Magazine
Ethyl ester or triglyceride: what actually changes at purchase
The chemical form of omega-3 fish oil is the first parameter to fix, because it determines which specification a supplier can quote from and which pharmacopoeial standard applies.
| Parameter | Ethyl ester (EE) | Triglyceride (TG) | What it changes at purchase |
|---|---|---|---|
| Concentration route | Reaches high EPA+DHA concentrations readily by distillation | Typically supplied at a lower concentration for the same oil weight | Compare cost per gram of EPA+DHA, not cost per kilogram of oil |
| Occurrence in nature | Not the form present in fish; produced by transesterification | The form naturally present in fish oil | Affects how the ingredient is described on some markets' labels |
| Reported bioavailability | Lower than TG in some studies when taken without food | Reported as slightly higher in some studies | Relevant to the finished product's dosage rationale, not to bulk handling |
| Cost position | Described by suppliers as more cost-effective for a given concentration | Typically priced above EE at equal EPA+DHA delivery | Drives landed cost per finished dose, not per kilogram |
| Oxidation limits | The same GOED limits apply | The same GOED limits apply | Form does not relax the PV, pAV or TOTOX requirements |
| Pharmacopoeial coverage | Covered by the USP monograph for Omega-3 Acid Ethyl Esters | Not covered by that monograph | Decides which specification a pharmaceutical filing must start from |
| Typical delivery form | Concentrated softgels | Softgels, emulsions, fortified foods | Determines whether a softgel line or an emulsion line is the better fit |
Both forms of omega-3 fish oil are legitimately supplied, and the choice is a formulation decision rather than a quality ranking. The practical rule when sourcing omega-3 fish oil is to name the form in writing before requesting a quotation, because a quotation for "omega-3 fish oil" without a declared form is an incomplete specification.
The oxidation limits that decide whether a lot is acceptable
Oxidation limits in omega-3 fish oil are the second parameter, and they are the ones most often left off a bulk quotation.
The reference values for omega-3 fish oil come from the GOED Voluntary Monograph, originally established by the Council for Responsible Nutrition in 2002, which sets limits for EPA and DHA oils that are deliberately tighter than those applied to other edible oils.
| Parameter | GOED Voluntary Monograph | Reference point elsewhere | Our published specification |
|---|---|---|---|
| Peroxide value (PV) | ≤ 5 meq/kg | 10 meq/kg for refined vegetable oils in most countries; 10 meq/kg for refined omega-3 oils under British Pharmacopoeia, European Pharmacopoeia and Australian rules; 20 meq/kg for extra virgin olive oil | ≤ 1.0 meq/kg |
| p-Anisidine value (pAV) | ≤ 20 | Not separately limited by the oil standards above | ≤ 10.0 |
| TOTOX (2 × PV + pAV) | ≤ 26 | Calculated value, not separately legislated | Not stated separately |
The omega-3 fish oil specification column above is our own published specification rather than an industry average, and it is listed on our omega-3 fish oil product page alongside acid value at ≤ 1.0 mg KOH/g.
Two points about those limits matter commercially. First, they are strict by design: most countries limit refined vegetable oils to a peroxide value of 10 meq/kg, and the British Pharmacopoeia, European Pharmacopoeia and Australian regulators apply 10 meq/kg to refined omega-3 oils, so the GOED value of 5 meq/kg sits below the general food-oil floor. Second, the limits are achievable: across more than 2,000 test results from published literature, third-party laboratories and GOED's own industry testing program, over 94% of products met the GOED peroxide limit and nearly 98% met the p-anisidine limit.
Why a low peroxide value is not proof of freshness
A low peroxide value on its own does not demonstrate that a lot of omega-3 fish oil is fresh, and a buyer who screens on PV alone can miss the parameter that would have flagged the problem.
In omega-3 fish oil, peroxide value measures primary oxidation. When polyunsaturated fatty acids oxidize, the first compounds formed are peroxides, which is why PV is the standard first-line test. The difficulty is that PV rises and then falls, because peroxides are consumed as oxidation proceeds - so an oil at an advanced stage of oxidation can report a low PV. Secondary oxidation products are measured separately as the p-anisidine value, and TOTOX is the calculation that combines both stages: TOTOX = 2 × PV + pAV.
There is also a scope limit to know before accepting a result. The p-anisidine test is recommended only for EPA and DHA oils in triglyceride or ethyl ester form that contain no natural pigments or added ingredients other than antioxidants. Strongly coloured oils, flavoured oils, and oils whose polar lipids do not dissolve readily can produce invalid pAV results, and where pAV cannot be determined reliably, TOTOX cannot be calculated at all.
For a purchase file, the practical consequence is to ask for PV, pAV and TOTOX together on the omega-3 fish oil lot, and to ask which analytical method was used. A quotation that reports only PV is reporting one of three numbers.
Concentration bands: 30–50% versus the 80–88% monograph range
The concentration band of omega-3 fish oil is the third parameter, and it is where most specification misunderstandings begin.
USP published its final monograph for Omega-3 Acid Ethyl Esters in July 2010, covering ethyl ester concentrates with an EPA+DHA content of 80%–88% on a mass basis, EPA at 43%–49.5% and DHA at 34.7%–40.3%. Because the scope is narrow, the monograph applies primarily to pharmaceutical applications, and its contaminant and quality limits differ in places from the GOED Voluntary Monograph - a difference that suppliers of such products need to track.
The omega-3 fish oil concentrate we supply is standardized to a total DHA+EPA content of 30%–50% with custom ratios available, so a buyer targeting a supplement or a fortified food is working in a different band from a buyer preparing a pharmaceutical filing. The two bands are not interchangeable and should not be compared as if they were competing quotations for the same material.
As a working rule, if the target is a pharmaceutical-grade filing, the monograph's 80%–88% band and its associated contaminant limits are the starting point. If the target is a dietary supplement or a functional food, the 30%–50% band is the usual range, and the decisive questions become the ratio and the oxidation limits rather than the concentration ceiling.
Ratio is specified as two numbers in the order EPA/DHA. Our product page lists 30/10 for a high-EPA grade, 10/30 for a high-DHA grade and 18/12 for a balanced grade, with custom ratios available, alongside the choice of ethyl ester or triglyceride form and acid value at ≤ 1.0 mg KOH/g.
COA checklist for bulk omega-3 fish oil
A usable certificate of analysis from a bulk omega-3 fish oil supplier lets a buyer confirm oxidation state, fatty acid composition, contaminants and origin from one document, and all four blocks should be present.
-
Oxidation and acidity
The oxidation block on an omega-3 fish oil COA should carry peroxide value, p-anisidine value and TOTOX as separate lines, together with the analytical method used and the acid value.
Where a supplier publishes limits tighter than the GOED monograph, the useful request is not the limit but the measured value on the actual lot. A published maximum of ≤ 1.0 meq/kg for peroxide value tells a buyer what the supplier intends to hold; it does not establish that the lot in front of them meets it.
-
Fatty acid composition and ratio
The composition block on an omega-3 fish oil COA should state EPA and DHA as separate percentages, give the ratio between them, and state the chemical form.
A single combined EPA+DHA figure is not sufficient where a label claim rests on one of the two fatty acids. The European Union's conditions for DHA-related claims are set on DHA alone, at a minimum of 200 mg per day for the maternal claim, so a formulator working toward that claim needs the DHA number by itself rather than a total.
-
Contaminants, storage and origin
The contaminant block on an omega-3 fish oil COA should cover heavy metals, PCBs, dioxins and PAHs against the limits of the target market. Our published specification states compliance with EU and USP limits for heavy metals, with PCBs, dioxins and PAHs below detectable levels or compliant with global standards.
Two items belong in the same file even though they are not analytical results. The first is the handling chain: our published storage condition is 2–8°C, protected from light and oxygen, and oxidation limits only hold if the oil was protected through transit and warehousing rather than only at the point of manufacture. The second is origin: the material is sourced from wild pelagic fish species, and where a finished label or a sustainability policy requires a named species or fishery, that should be requested before the order rather than after.
Claims and regulatory position by market
What may be said about a finished product made with omega-3 fish oil differs sharply between markets, and the difference is wider for omega-3 than for most botanicals because these are recognized nutrients rather than unapproved herbal ingredients.
In the European Union, a health claim for DHA and maternal intake is authorized under Article 14(1)(b), on the condition that the food provides a daily intake of at least 200 mg of DHA, and that pregnant and lactating women are informed that the effect is obtained with a daily intake of 200 mg of DHA in addition to the recommended daily intake for adults of 250 mg DHA and EPA. The EU register lists the entry as authorised under Commission Regulation (EU) No 440/2011, and EFSA has separately assessed claims relating to DHA and EPA for normal brain function, normal vision and normal cardiac function.
In the United States the position gives the documentation a different job. There is no FDA-approved over-the-counter omega-3 medication; FDA manages omega-3 dietary supplements as food, while prescription omega-3 products are indicated as an adjunct to diet to reduce triglycerides in adults with severe hypertriglyceridemia, at 4 g per day. The same review records the consequences that matter to a supplement buyer: variable content, inconsistencies with labeled quantities, and problems with product quality and impurities have all been documented in this category.
On evidence strength, the same review summarizes a systematic review of 79 clinical studies which concluded, on high-quality evidence, that EPA and DHA do not have important positive or negative effects on mortality or cardiovascular events. It also notes that the DHA+EPA combination arms of two large cardiovascular outcome trials did not meet their primary endpoints, while a prescription EPA-only product did.
The commercial reading is that the documentation burden sits with the supplier rather than with the claim. A package that reports oxidation state, composition and contaminants on the actual lot is what a formulator can build on; a dossier that leads with benefit language is not, in either market.
What the 2025 supply data means for a buying plan
Volume growth alongside a value decline is a buyer's market for omega-3 fish oil itself, but it is not a reason to relax the specification.
Global volume grew 2.6% in 2025 to 136,000 metric tons while value fell 4.3% to $2.53 billion. GOED attributes the decline to a price correction rather than weaker demand, following the 2023–2024 El Niño that constrained Peruvian anchovy oil supply, with prices normalizing in late 2024 and volume projected to grow 3–4% a year through 2028.
Two supply-side risks belong in a sourcing plan. The supply chain diversified after the most recent El Niño but remains dependent on a small number of origins, so single-origin exposure stays a live risk. And the applications did not grow evenly: pharmaceuticals were held back by generic competition in the United States, while supplements, food and beverage, and pet nutrition carried the growth - which is where most bulk buyers are competing.
Frequently asked questions
Q: Is Ethyl Ester Or Triglyceride Better For A Softgel?
A: For omega-3 fish oil, neither is universally better; they are different specification routes. Ethyl ester reaches high EPA+DHA concentrations more readily by distillation and is generally the more cost-effective route to a given concentration, while triglyceride is the form naturally present in fish and is reported as slightly better absorbed in some studies. For a softgel, the decisive question is which concentration and ratio the label claim requires.
Q: What Oxidation Limits Should I Require In A Bulk Omega-3 Contract?
A: For bulk omega-3 fish oil, start from the GOED Voluntary Monograph: peroxide value ≤ 5 meq/kg, p-anisidine value ≤ 20, and TOTOX ≤ 26. Tighter limits are legitimate to require, but pair them with the measured value on each lot rather than the limit alone, because a specification describes what a supplier intends to hold.
Q: Why Would A Low Peroxide Value Sit Next To A High TOTOX?
A: Because peroxide value measures only primary oxidation and can fall as oxidation advances, while TOTOX adds the secondary stage: TOTOX = 2 × PV + pAV. A high p-anisidine value against a low peroxide value indicates an oil that has moved past the peroxide stage rather than one that is fresh.
Q: What Is The Difference Between The USP Monograph And The GOED Voluntary Monograph?
A: They are different instruments with different scopes, and any bulk omega-3 fish oil supplier should be able to say which one applies to the lot being quoted. The USP Omega-3 Acid Ethyl Esters monograph covers ethyl ester concentrates at 80%–88% EPA+DHA and applies mainly to pharmaceutical use, while the GOED Voluntary Monograph is an industry standard setting oxidation and quality limits for EPA and DHA oils generally. Contaminant and quality limits differ between the two.
Q: Can Omega-3 Fish Oil Be Supplied In Powder Form?
A: Yes, as a processed format of omega-3 fish oil rather than as a raw oil. Our product page lists powder processing among the available customizations, alongside canned capsules and compressed tablets, which is the usual route when the target is a dry blend or a stick pack rather than a softgel.
Q: What MOQ And Shelf Life Should A Buyer Expect?
A: For omega-3 fish oil, our published minimum order quantity is 1 kg for sampling and testing, with bulk orders quoted by the metric ton, and shelf life is stated at 24 months from manufacture when stored at 2–8°C, protected from light and oxygen. Payment terms are 100% before shipment, by bank transfer, Escrow, PayPal, Western Union or MoneyGram.
Next step: request the specification package before the quotation
A bulk omega-3 fish oil supplier quotation becomes comparable only once four things are on the table: the chemical form, the oxidation limits with the analytical method, the concentration band with the EPA:DHA ratio, and the contaminant and origin documentation. Our published specification covers the first three.
You can request a current-lot COA, a sample, and a quotation for a specific form, concentration and ratio through our inquiry form, or reach the technical team through the contact page. Buyers comparing this ingredient against other supplement actives can start from our supplement ingredients range, and readers who want the consumer-facing benefits and side-effect discussion rather than the procurement view will find it in our omega-3 fish oil benefits and side effects guide.
This article is written for ingredient sourcing, formulation and regulatory professionals. It is not medical advice and is not intended to diagnose, treat, cure or prevent any disease.
Sources
- Global Organization for EPA and DHA Omega-3s (GOED). Oxidation in Omega-3 Oils: An Overview (white paper), as published in OFI Magazine, February 2023. https://www.ofimagazine.com/content-images/news/OFI-Feb-2023-p2830-updated.pdf
- GOED. 2026 Ingredient Market Report, as reported by Nutraceuticals World, 23 July 2026. https://www.nutraceuticalsworld.com/breaking-news/goed-publishes-2026-ingredient-market-report/
- United States Pharmacopeia. Omega-3 Acid Ethyl Esters monograph coverage, as reported by Nutraceuticals World, 27 July 2010. https://www.nutraceuticalsworld.com/breaking-news/usp-issues-omega-3-ee-monograph/
- European Commission. Food and Feed Information Portal, EU Health Claims Register, entry POL-HC-6201 (DHA, maternal intake). https://ec.europa.eu/food/food-feed-portal/screen/health-claims/eu-register/details/POL-HC-6201
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the substantiation of health claims related to DHA and EPA. EFSA Journal 2011;9(4):2078. https://www.efsa.europa.eu/en/efsajournal/pub/2078
- Hilleman DE, Wiggins BS, Bottorff MB. Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review. Advances in Therapy 2020;37(2):656–670. https://pmc.ncbi.nlm.nih.gov/articles/PMC6999166/